Frederique Larousserie
Overview
Explore the profile of Frederique Larousserie including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
94
Citations
1442
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Boudou-Rouquette P, Claude L, Larousserie F, Gouin F, Gaspar N
Bull Cancer
. 2025 Mar;
PMID: 40058982
No abstract available.
2.
Mouren A, Chansavang A, Hamzaoui N, Srikaran A, Laurent-Puig P, Marisa L, et al.
Fam Cancer
. 2024 May;
23(4):627-634.
PMID: 38763984
De novo germline pathogenic variants (gPV) of the BReast CAncer 1 (BRCA1) gene are very rare. Only a few have been described up to date, usually in patients with a...
3.
Guillois C, Yang S, Biau D, Feydy A, Larousserie F
Skeletal Radiol
. 2023 Sep;
53(5):1003-1009.
PMID: 37733062
Chondroblastoma is a rare benign cartilaginous tumor mostly confined to the epiphyses and apophyses. Cases outside the epiphyseal region are exceedingly rare. Extramedullary chondroblastomas are exceptional; to our knowledge, only...
4.
Bertin H, Peries S, Amiaud J, Van Acker N, Perrot B, Bouvier C, et al.
Cancers (Basel)
. 2023 Feb;
15(4).
PMID: 36831348
Background-The purpose of this study was to investigate the bone resorption, as well as the vascular and immune microenvironment, of jaw osteosarcomas (JO) and to correlate these features with patient...
5.
Tlemsani C, Larousserie F, De Percin S, Audard V, Hadjadj D, Chen J, et al.
Int J Mol Sci
. 2023 Jan;
24(2).
PMID: 36674874
This review provides an overview of histopathology, clinical presentation, molecular pathways, and potential new systemic treatments of high-grade chondrosarcomas (CS), including grade 2−3 conventional, dedifferentiated, and mesenchymal CS. The diagnosis...
6.
Bodard S, Lassalle L, Larousserie F, Guinebert S, Hacquart T, Campagna R, et al.
BMC Cancer
. 2022 Dec;
22(1):1305.
PMID: 36513982
Background: Separating benign from malignant soft-tissue masses often requires a biopsy. The objective of this study was to assess whether shear-wave elastography (SWE) helped to separate benign from malignant soft-tissue...
7.
Lacroix M, Aouad T, Feydy J, Biau D, Larousserie F, Fournier L, et al.
Diagn Interv Imaging
. 2022 Oct;
104(1):18-23.
PMID: 36270953
Artificial intelligence (AI) is increasingly being studied in musculoskeletal oncology imaging. AI has been applied to both primary and secondary bone tumors and assessed for various predictive tasks that include...
8.
Tordjman M, Honore C, Crombe A, Bouhamama A, Feydy A, Dercle L, et al.
Eur Radiol
. 2022 Aug;
33(2):1162-1173.
PMID: 35980435
Objectives: Synovial sarcomas (SS) of the extremities are rare soft tissue sarcomas that are more common in young adults. We deciphered the imaging phenotype of SS with the aim to...
9.
Cyrta J, Benoist C, Masliah-Planchon J, Vieira A, Pierron G, Fuhrmann L, et al.
Mod Pathol
. 2022 Jun;
35(11):1624-1635.
PMID: 35697931
Breast carcinomas (BC) with osteoclast-like giant cells (OGC) are rare. Despite their distinct stromal features, their molecular characteristics remain unknown. Here, we report comprehensive clinico-pathological and molecular findings for 27...
10.
Tauziede-Espariat A, Pierre T, Wassef M, Castel D, Riant F, Grill J, et al.
Acta Neuropathol Commun
. 2022 Jun;
10(1):81.
PMID: 35642047
The International Society for the Study of Vascular Anomalies (ISSVA) has defined four vascular lesions in the central nervous system (CNS): arteriovenous malformations, cavernous angiomas (also known as cerebral cavernous...